Publications

Showing

0

out of

0

results

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.

Eliassen CF, Reinvang I, Selnes P,

December 31, 2016

White matter hyperintensity microstructure in amyloid dysmetabolism.

Kalheim LF, Bjornerud A, Fladby T,

December 31, 2016

Impaired synaptic function is linked to cognition in Parkinson's disease.

Selnes P, Stav AL, Johansen KK,

December 31, 2016

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.

Almdahl IS, Lauridsen C, Selnes P,

December 31, 2016

Convergent Results from Neuropsychology and from Neuroimaging in Patients with Mild Cognitive Impairment.

Eliassen CF, Reinvang I, Selnes P,

December 31, 2016

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample.

Eckerstrom M, Gothlin M, Rolstad S,

December 31, 2016

Psychometric properties of a Norwegian adaption of the Barratt Impulsiveness Scale-11 in a sample of Parkinson patients, headache patients, and controls.

Lindstrøm JC, Wyller NG, Halvorsen MM,

November 22, 2016

Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities.

Kalheim LF, Selnes P, Bjørnerud A,

November 20, 2016

Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.

Holmøy T, Beiske AG, Zarnovicky S,

October 17, 2016

Reperfusion therapy in stroke cases with unknown onset.

Rønning OM.

September 12, 2016